Immuron Ltd has released a press release.
US NIH to Fund Second IMC Fatty Liver Study - Pediatric NASH
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immuron
- Travelan to be Stocked by US Distributor Medique Products
- Immuron to Cooperate with Universities on Autism Research
- Immuron to repay outstanding Convertible Note in cash
- IMC Signs Shigella Vaccine Developmt Agreement with US Army
- Travelan and Protectyn Are Now Available For Sale in China
Later from Immuron
- Immuron Expands Collaborate with US Navy
- Appendix 4E and Annual Report
- Immurons $6M Rights Issue Closes Oversubscribed
- NASH Phase II Trial reaches 75% of Patient Recruitment
- Immurons NASH Phase II Trial Achieves 100 Patient Milestone
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron